Alzheimer's disease (AD) is the most common cause of dementia worldwide. The etiology is multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential rise in the number of cases of AD, emphasizing the need for developing an effective treatment. AD also imposes ...
The journal explores all the virtual issues in neurology. The journal focuses on advances in research and clinical care in neurology and related disciplines. The journal makes a room for information on various neurological conditions or disorders and their management like Alzheimer’s disease, aneurysm...
Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation Daniel C. Shippy & Tyler K. Ulland Article 02 September 2023 | Open Access TNFα induced by DNA-sensing in macrophage compromises retinal pigment epithelial (RPE) barrier function Michael Twarog ...
Welcome to the 19th International Conference on Alzheimer's Disease and Dementia, set to take place on August 04-05, 2025, in Berlin, Germany. Under the theme "Rethinking Memory: Future Directions in Alzheimer's Diagnosis, Treatment, and Care," this conference provides a vital platform for pro...
Alzheimer’s disease is the most common form of dementia. Notwithstanding the huge investments in drug development, only one disease-modifying treatment has been recently approved. Here we present a single-cell-led systems biology pipeline for the identi
'Look at all this we don't understand': Study unravels whole new layer of Alzheimer's disease By Nicoletta Lanese published May 22, 2024 A new study begins to unpack an understudied aspect of brain biology and Alzheimer's disease. Alzheimers & Dementia Active ingredient in Viagra tied ...
Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease. Wang P1,Zheng X1,Guo Q1,Yang P1,Pang X1,Qian K1,Lu W2,Zhang Q3,Jiang X1. 公司简介 齐氏生物科技有限公司成立于2009年,是一家专注于原代细胞培养和筛选、体外药物代谢和药物间相互作用评价产品...
A review of Alzheimer's disease pathology, conventional treatments and their limitations, as well as emerging and potential therapies including monoclonal antibodies, metabolic therapies, and stem cell therapies. Read More Precision for Medicine Precision for Medicine is an industry-leading global CRO, ...
Hear from experts on the latest innovations for diagnostic research studying diseases from Alzheimer’s, Oncology, and Diabetes by measuring protein, lipid, metabolite biomarkers and PFAS using standardized LC-MS workflows for clinical research and environmental safety. ...
Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease. Wang P1,Zheng X1,Guo Q1,Yang P1,Pang X1,Qian K1,Lu W2,Zhang Q3,Jiang X1. 公司简介 齐氏生物科技有限公司成立于2009年,是一家专注于原代细胞培养和筛选、体外药物代谢和药物间相互作用评价产品...